Evidence map›Paper›PMID 31312138›Full record

ReviewFrontiers in pharmacology2019

The Insula: A Brain Stimulation Target for the Treatment of Addiction.

Christine Ibrahim, Dafna S Rubin-Kahana, Abhiram Pushparaj, Martin Musiol, Daniel M Blumberger, Zafiris J Daskalakis, Abraham Zangen, Bernard Le Foll

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 4 pooled it
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 4 syntheses or guidelines pooled it, 130 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Impairment of the GABAergic system in the anterior insular cortex of heroin-addicted males.European archives of psychiatry and clinical neuroscience · 2025
    Article
  17. Review
  18. Review
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Christine IbrahimTranslational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Dafna S Rubin-KahanaTranslational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Abhiram PushparajQunuba Sciences, Toronto, ON, Canada.
Martin MusiolIronstone Product Development, Toronto, ON, Canada.
Daniel M BlumbergerDepartment of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Zafiris J DaskalakisDepartment of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Abraham ZangenDepartment of Life Sciences and the Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Bernard Le FollTranslational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada.
University of Toronto · CAAltasciences (Canada) · CABen-Gurion University of the Negev · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Substance use disorders (SUDs) are a growing public health concern with only a limited number of approved treatments. However, even approved treatments are subject to limited efficacy with high long-term relapse rates. Current treatment approaches are typically a combination of pharmacotherapies and behavioral counselling. Growing evidence and technological advances suggest the potential of brain stimulation techniques for the treatment of SUDs. There are three main brain stimulation techniques that are outlined in this review: transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and deep brain stimulation (DBS). The insula, a region of the cerebral cortex, is known to be involved in critical aspects underlying SUDs, such as interoception, decision making, anxiety, pain perception, cognition, mood, threat recognition, and conscious urges. This review focuses on both the preclinical and clinical evidence demonstrating the role of the insula in addiction, thereby demonstrating its promise as a target for brain stimulation. Future research should evaluate the optimal parameters for brain stimulation of the insula, through the use of relevant biomarkers and clinical outcomes for SUDs.

Indexed as

addictionbrain stimulationdeep brain stimulation (DBS)insulatranscranial direct current stimulation (tDCS)transcranial magnetic stimulation (TMS)

Identifiers

PMID31312138
PMCPMC6614510
OpenAlexW2954290071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.